Objective Measures of Behavior Manifestations in Adult ADHD and Differentiation from Participants with Bipolar II Disorder, Borderline Personality Disorder, Participants with Disconfirmed ADHD as Well as Normative Participants

Hanna Edebol, Lars Helldin, Torsten Norlander, Hanna Edebol, Lars Helldin, Torsten Norlander

Abstract

Background: The present study evaluated two psychometric instruments derived from the objective measurement of adult ADHD using the Quantified Behavior Test Plus. The instruments were examined in ADHD versus a clinical group with overlapping symptoms including borderline personality disorder and bipolar II disorder, and another clinical group with participants assessed for but disconfirmed a diagnosis of ADHD as well as adult normative participants.

Methods: The Quantified Behavior Test Plus includes Continuous Performance Testing and a Motion Tracking System with parameters related to attention and activity operationalized as the cardinal symptoms of ADHD and then summarized into a Weighed Core Symptoms scale with ten cut-points ranging from 0 to 100. A categorical predictor variable called Prediction of ADHD was used to examine the levels of sensitivity and specificity for the Quantified Behavior Test Plus with regard to ADHD.

Results: The Weighed Core Symptoms scale separated ADHD and normative participants from each other as well as from the two clinical reference groups. The scale reported highest levels of core symptoms in the ADHD group and the lowest level of core symptoms in the normative group. Analyses with Prediction of ADHD yielded 85 % specificity for the normative group, 87 % sensitivity for the ADHD group, 36 % sensitivity for the bipolar II and borderline group and 41 % sensitivity for the group with a disconfirmed diagnosis of ADHD.

Conclusions: The Weighed Core Symptoms scale facilitated objective assessment of adult ADHD insofar that the ADHD group presented more core symptoms than the other two clinical groups and the normative group. Sensitivity for the Quantified Behavior Test Plus was lower in complex clinical groups with Bipolar II disorder, Borderline disorder and in patients with a disconfirmed diagnosis of ADHD. The psychometric instruments may be further evaluated with regard to well-documented and effective treatment programs for ADHD core symptoms.

Keywords: Adults; Attention Deficit Hyperactivity Disorder; Behavior; Hyperactivity; Objective measures; Psychometrics; Quantified Behavior Test Plus..

References

    1. Kessler RC, Adler L, Gruber MJ, Sarawate CA, Spencer T, van Brunt DL. Validity of the World Health organization adult ADHD self-report scale (ASRS) screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16:52–65.
    1. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United Sates: results from the national comorbidity survey replication. Am J Psychiatry. 2006;163:716–23.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 4th. Washington DC: American Psychiatric Pub; 2000.
    1. Murphy KR, Adler LA. Assessing attention-deficit/hyperactivity disorder in adults: Focus on rating scales. J Clin Psychiatry. 2004; 65:8–11.
    1. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150: 1792–8.
    1. Wilens TE, Biederman J, Faraone SV, Marleton MK, Westerberg D, Spencer TJ. Presenting ADHD symptoms, and comorbid disorders in clinically referred adults with ADHD. J Clin Psychiatry . 2009;40:1557–62.
    1. Giedd JN. Bipolar disorder and attention-deficit/hyperactivity disorder in children and adolescents. J Clin Psychiatry. 2000;61: 31–4.
    1. Kent L, Craddock N. Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder? J Affect Disord . 2003;73:211–21.
    1. Weiss MD, Weiss JR. A guide to the treatment of adults with ADHD. J Clin Psychiatry. 2004;65:27–37.
    1. Woods SP, Lovejoy DW, Ball JD. Neuropsychological characteristics of adults with ADHD: a comprehensive review of initial studies. Clin Neuropsychol. 2002;16:12–34.
    1. Adler LA. Clinical presentations of adult patients with ADHD. J Clin Psychiatry. 2004;65:8–11.
    1. Jackson B, Farrugia D. Diagnosis and treatment of adults with attention deficit hyperactivity disorder. J Couns Dev. 1997;75:312–9.
    1. Spencer TJ. ADHD treatment across the life cycle. J Clin Psychiatry . 2004;65:22–6.
    1. Murphy K, Barkley RA. Attention deficit hyperactivity disorder in adults: comorbidities and adaptive impairments. Compr Psychiatry . 1996;37:393–401.
    1. Downey K, Stelson F, Pomerleau O, Giordiani B. Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population. J Nerv Ment Dis. 1997;185:32–8.
    1. Marshall P, Schroeder R, O´Brien J, et al. Effectiveness of symptom validity measures in identifying cognitive and behavioral symptom exaggeration in adult attention deficit hyperactivity disorder. Clin Neuropsychol. 2010;24:1204–37.
    1. Lis S, Baer N, Stein-en-Nosse C, Gallhofer B, Sammer G, Kirsch P. Objective measurement of motor activity during cognitive performance in adults with attention-deficit/hyperactivity disorder. Acta Psychiatr Scand. 2010;122:285–94.
    1. Polcari A, Fourligas N, Navalta C, Teicher MH. Hyperactivity persists in male and female adults with ADHD and remains a highly discriminative feature of the disorder. Proceedings of the 57th annual meeting; 2010 Oct 26-31; New York, USA. 2010.
    1. Epstein JN, Erkanli A, Conners CK, Klaric J, Costello JE, Angold A. Relations between continuous performance measures and ADHD behaviors. J Abnorm Child Psychol. 2003;31:543–54.
    1. Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology. 2004;18:485–503.
    1. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/ hyperactivity disorder: a meta-analytic review. Biol Psychiatry . 2005;57:1336–46.
    1. Boonstra AM, Oosterlaan J, Sergeant JA, Buitelaar JK. Executive functioning in adult ADHD: a meta-analytic review. Psychol Med . 2005;35:1097–108.
    1. Frazier TW, Demaree HA, Youngstorm EA. Meta-analysis of intellectual and neuro-psychological test performance in attention-deficit/ hyperactivity disorder. Neuropsychology. 2004;18:543–55.
    1. Losier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: A meta-analysis review. J Child Psychol Psychiatry. 1996;37:971–87.
    1. Heiser P, Frey J, Smidt C, et al. Objective meaurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. Eur Child Adolesc Psychiatry. 2004;13:100.
    1. Tabori-Kraft J, Sorensen M, Kerguard M, Dalsgaard S, Thomsen PH. Is MMAT (Quotient) useful for monitoring the effect of stimulants on hyperactivity and inattention? A brief report. Eur Child Adolesc Psychiatry. 2007;16:347–351.
    1. Teicher M, Polcari A, McGreenery C. Utility of objective measures of activity and attention in the assessment of therapeutic response to stimulants in children with ADHD. J Child Adolesc Psychopharmacol . 2008;18:265–270.
    1. Teicher M, Lowen S, Polcari A, Foley M, McGreenery C. Novel strategy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD. J Child Adolesc Psychopharmacol. 2004;14:2.
    1. Fuchs T, Birbaumer N, Luttzenberger W, Gruzelier JH, Kaiser J. Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: a comparison with methylphenidate. Appl Psychophysiol Biofeedback. 2003;28:1–12.
    1. Loo SK, Barkley RA. Clinical utility of EEG in Attention Deficit Hyperactivity Disorder. Appl Neuropsychol. 2005;12:64–76.
    1. Arns M, Ridder S, Srehl U, Breteler M, Coenen A. Efficiacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clin EEG Neurosci . 2009;40:180–9.
    1. Corbett B, Stanzcak DE. Neuropsychological performance of adults evidencing attention deficit hyperactivity disorder. Arch Clin Neuropsychol. 1999;14:373–87.
    1. Seidman LJ, Biederman J, Faraone SV, Weber W, Ouellette C. Toward defining a neuropsychology of attention deficit-hyperactivity disorder: Performance of children and adolescents from a large clinically referred sample. J Consult Clin Psychol . 1997;65:50–60.
    1. Epstein JN, Johnson DE, Varia IM, Conners CK. Neuropsychological assessment of response inhibition in adults with ADHD. J Clin Exp Neuropsychol. 2001;23:362–71.
    1. Katz LJ, Wood DS, Goldstein G, Auchenbach RC, Geckle M. The utility of neuropsychological tests in evaluation of Attention- Deficit/Hyperactivity Disorder (ADHD) in adults. Assessment . 1998;5:45–51.
    1. Walker AJ, Shores EA, Trollor JN, Lee T, Sachdev PS. Neuropsychological functioning of adults with attention deficit hyperactivity disorder. J Clin Exp Neuropsychol. 2000;22:115–24.
    1. Edebol H, Helldin L, Holmberg E, Gustafsson S, Norlander T. In search for an objective measure of hyperactivity, impulsivity and inattention in adult attention deficit hyperactivity disorder using the quantified behavior test plus. Eur J Psychol. 2011;7:443–57.
    1. Edebol H, Helldin L, Norlander T. Measuring adult attention deficit hyperactivity disorder using the quantified behavior test plus. Psychol J. 2011. [In review]
    1. QbTech AB. QbTest Plus Clinical Manual. Gothenburg: QbTech AB; 2010. a.
    1. QbTech AB. QbTest Plus Clinical Manual. Gothenburg: QbTech AB; 2010. b.
    1. Luborsky L. Clinicians’ judgments of mental health. Arch Gen Psychiatry. 1962;7:407–17.
    1. Kessler RC, Adler L, Ames M, et al. The world health organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35:245–56.
    1. Kessler RC, Ustün TB. The world mental health (WMH) survey initiative version of the world health organization (WHO) composite international diagnostic interview (CIDI) Int J Methods Psychiatr Res. 2004;13:93–121.
    1. Shaffer D. Attention deficit hyperactivity disorder in adults. Am J Psychiatry. 1994;151:633–38.
    1. Arcia E, Conners KC. Gender differences in ADHD? J Dev Behav Pediatr. 1998;19:77–83.
    1. Biederman J, Faraone SV, Monuteaux MC, Bober M, Cadogen E. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biol Psychiatry. 2004;55:692–700.
    1. Barkley RA, Murphy KR, Fischer M. ADHD in adults- what the science says. New York: The Guilford Press; 2008.
    1. Barkley RA. Inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121:65–94.
    1. Glickman M. Objective measures of motion, attention and executive function in the identification of attention deficit hyperactivity disorder among children with major depression [dissertation] Dallas (TX): Texas Southwestern Medical Center. 2003.
    1. Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK, Van Someren EJ. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep. 2007;30:433–442.
    1. Tuisku K, Virkkunen M, Holi M, Et A. Antisocial violent offenders with attention deficit hyperactivity disorder demonstrate akathisia-like hyperactivity in three-channel actometry. J Neuropsych Clin N . 2003;15:94–9.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa